Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Polycystic Ovary Syndrome
Type
Interventional
Phase
Phase 4
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Probiotic vs placebo (double-blinded) vs metformin (open-label)Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Only the probiotic and placebo are blinded, metformin is an open intervention armPrimary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 45 years
Gender
Only males

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04593459
Collaborators
  • Institut AllergoSan
  • Winclove Probiotics
Investigators
Principal Investigator: Barbara Obermayer-Pietsch, Prof. MD Medical University of Graz, Division of Endocrinology and Diabetology